Fecal biomarker-guided care for ulcerative colitis
Part of Digestive system clinical trials.
This study tests whether monitoring ulcerative colitis with stool-based markers—simple, non-invasive tests—can help guide treatment as effectively as the usual care approach. It aims to see if this strategy helps you stay in remission and avoid flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had ulcerative colitis for at least 6 months
- Your symptoms are well controlled—like having 2 or fewer bowel movements per day and little to no blood or urgency
- You have had a colonoscopy in the last 3 months showing your colon is healing well (a Mayo score of 1 or less)
- You have been on the same treatment plan (like mesalamine, immune-suppressing drugs, biologic infusions, or JAK inhibitors) for at least 2 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether early stool tests (fecal immunochemical test and calprotectin) can predict when ulcerative colitis symptoms might return. It is for people who have never taken biologic medications.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
This study looks at stool samples to see if certain markers can quickly tell whether a biologic medicine is starting to work for moderate-to-severe ulcerative colitis. If successful, this could help doctors make faster, smarter treatment decisions.
This study looks at whether a simple stool test can tell if treatment is healing the gut lining in people with moderate to severe ulcerative colitis who are starting their first biologic medicine. If it works, this test might help doctors adjust treatment earlier.
This study tests whether a combination of fecal transplant (transferring healthy stool into your gut) and dietary changes can help control inflammation in people recently diagnosed with active ulcerative colitis. It may offer a new treatment option before starting stronger medications.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
Hear when a new Noninvasive Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.